RYTMRhythm Pharmaceuticals, Inc.

$6B

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$11M

Net Income

-$11M

EPS (Diluted)

$-1.09

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$7M

Stock-Based Comp.

$298,000

Balance Sheet

Total Assets

$37M

Total Liabilities

$5M

Stockholders' Equity

$32M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$11M	-$6M	-62.8%
Net Income	-$11M	-$6M	-70.5%

RYTM FY 2015 Earnings — Rhythm Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena